EUROPE METABOLOMICS MARKET FORECAST 2019-2027

  • You are here:
  • Home
  • Reports
  • EUROPE METABOLOMICS MARKET FORECAST 2019-2027

EUROPE METABOLOMICS MARKET FORECAST 2019-2027

The Europe metabolomics market is predicted to register a CAGR of 12.09% during the forecasted period. The stable economic conditions in the region, and the metabolomics symposiums conducted, are the primary factors pushing the growth of the market in the region. The market for metabolomics in the European region is assessed based on the market regions of Italy, Germany, France, Spain, the United Kingdom, and the Rest of Europe. The European market region comes second to North America in terms of importance. One of the major strategies undertaken by the players in the market is the new product development and launch. Germany is one of the major countries of the European region that strongly advocates R&D activities.

EUROPE METABOLOMICS MARKET FORECAST 2019-2027

Request free sample

The Europe metabolomics market is predicted to register a CAGR of 12.09% during the forecasted period. The stable economic conditions in the region, and the metabolomics symposiums conducted, are the primary factors pushing the growth of the market in the region.

The market for metabolomics in the European region is assessed based on the market regions of Italy, Germany, France, Spain, the United Kingdom, and the Rest of Europe. The European market region comes second to North America in terms of importance. One of the major strategies undertaken by the players in the market is the new product development and launch. Germany is one of the major countries of the European region that strongly advocates R&D activities. The healthcare sector of the country is adopting new technology at a faster rate than any other country in the region. This is due to the large presence of global healthcare companies. The country witnesses a rising number of cancer cases every year, which is expected to increase even more in the future. Thus, people have started preferring personalized medicine. There have been innovations in personalized medicine, due to which the technological advancements in the healthcare sector of the country would increase. Thus, the metabolomics market in the region is estimated to propel positively during the forecasted period.

The market has the presence of many established companies with a vast range of product portfolio. One such company is the Biocrates Life Sciences AG (Biocrates), a biotechnology company, and a developer of targeted phenotyping solutions. The company supplies tools for metabolic signatures of diseases.

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

  1. RESEARCH SCOPE
    • STUDY GOALS
    • SCOPE OF THE MARKET STUDY
    • WHO WILL FIND THIS REPORT USEFUL?
    • STUDY AND FORECASTING YEARS
  2. RESEARCH METHODOLOGY
    • SOURCES OF DATA
      • SECONDARY DATA
      • PRIMARY DATA
    • TOP-DOWN APPROACH
    • BOTTOM-UP APPROACH
    • DATA TRIANGULATION
  3. EXECUTIVE SUMMARY
    • MARKET SUMMARY
    • KEY FINDINGS
      • METABOLOMICS BIOINFORMATICS TOOLS AND SERVICES ARE THE FASTEST GROWING PRODUCT & SERVICE
      • BIOMARKER DISCOVERY IS THE WIDELY USED APPLICATION
      • CANCER IS THE MOST PREVALENT INDICATION
  1. MARKET DYNAMICS
    • MARKET SCOPE & DEFINITION
    • MARKET DRIVERS
      • GROWING INVESTMENTS IN THE METABOLOMICS DOMAIN BY THE PUBLIC AND PRIVATE SECTORS
      • RISE IN THE DEMAND FOR PERSONALIZED MEDICINES
      • UPSURGE IN THE INCIDENCES OF CHRONIC DISEASE
    • MARKET RESTRAINTS
      • LACK OF SKILLED PROFESSIONALS IN METABOLOMICS
      • HIGH COST OF THE INSTRUMENTS
    • MARKET OPPORTUNITIES
      • EMERGING APPLICATION OF METABOLOMICS IN HUMAN NUTRITION
      • GROWING USAGES IN THE EARLY DETECTION OF CHRONIC DISEASES
    • MARKET CHALLENGES
      • COMPLEX AND DIVERSE NATURE OF THE BIOLOGICAL SAMPLES
  1. MARKET BY PRODUCT & SERVICE
    • METABOLOMICS INSTRUMENTS
      • SEPARATION TECHNIQUE
      • DETECTION TECHNIQUE
    • METABOLOMICS BIOINFORMATICS TOOLS AND SERVICES
  2. MARKET BY APPLICATION
    • BIOMARKER DISCOVERY
    • DRUG DISCOVERY
    • TOXICOLOGY TESTING
    • NUTRIGENOMICS
    • FUNCTIONAL GENOMICS
    • PERSONALIZED MEDICINE
    • OTHER APPLICATION
  3. MARKET BY INDICATION
    • CANCER
    • CARDIOVASCULAR DISORDERS
    • NEUROLOGICAL DISORDERS
    • INBORN ERRORS OF METABOLISM
    • OTHER INDICATION
  4. KEY ANALYTICS
    • PORTER’S FIVE FORCES MODEL
      • THREAT OF NEW ENTRANTS
      • THREAT OF SUBSTITUTE
      • BARGAINING POWER OF BUYERS
      • BARGAINING POWER OF SUPPLIERS
      • THREAT OF COMPETITIVE RIVALRY
    • VALUE CHAIN ANALYSIS
    • MARKET TRENDS
    • OPPORTUNITY MATRIX
  5. GEOGRAPHICAL ANALYSIS
    • EUROPE
      • GERMANY
      • FRANCE
      • THE UNITED KINGDOM
      • ITALY
      • SPAIN
      • REST OF EUROPE
  1. COMPETITIVE LANDSCAPE
    • MARKET POSITION ANALYSIS
    • COMPANY PROFILES
      • AGILENT TECHNOLOGIES, INC.
      • APICAL SCIENTIFIC SDN BHD
      • BIOCRATES LIFE SCIENCES AG
      • BIO-RAD LABORATORIES, INC.
      • BRUKER CORPORATION
      • CREATIVE PROTEOMICS
      • DANAHER CORPORATION (SCIEX)
      • HUMAN METABOLOME TECHNOLOGIES, INC.
      • KORE TECHNOLOGY LIMITED
      • LECO CORPORATION
      • METABOLON INC.
      • PERKINELMER, INC.
      • SHIMADZU CORPORATION
      • THERMO FISHER SCIENTIFIC INC.
      • WATERS CORPORATION

TABLE LIST

TABLE 1: EUROPE METABOLOMICS MARKET, 2019-2027 ($ MILLION)

TABLE 2: EUROPE METAGENOMICS MARKET, BY PRODUCT & SERVICE, 2019-2027 ($ MILLION)

TABLE 3: EUROPE METABOLOMICS INSTRUMENTS MARKET, 2019-2027 ($ MILLION)

TABLE 4: EUROPE METABOLOMICS INSTRUMENTS MARKET, BY TYPE, 2019-2027 ($ MILLION)

TABLE 5: EUROPE SEPARATION TECHNIQUE MARKET, 2019-2027 ($ MILLION)

TABLE 6: EUROPE DETECTION TECHNIQUE MARKET, 2019-2027 ($ MILLION)

TABLE 7: EUROPE METABOLOMICS BIOINFORMATICS TOOLS AND SERVICES MARKET, 2019-2027 ($ MILLION)

TABLE 8: EUROPE METABOLOMICS MARKET, BY APPLICATION, 2019-2027 ($ MILLION)

TABLE 9: EUROPE BIOMARKER DISCOVERY MARKET, 2019-2027 ($ MILLION)

TABLE 10: EUROPE DRUG DISCOVERY MARKET, 2019-2027 ($ MILLION)

TABLE 11: EUROPE TOXICOLOGY TESTING MARKET, 2019-2027 ($ MILLION)

TABLE 12: EUROPE NUTRIGENOMICS MARKET, 2019-2027 ($ MILLION)

TABLE 13: EUROPE FUNCTIONAL GENOMICS MARKET, 2019-2027 ($ MILLION)

TABLE 14: EUROPE PERSONALIZED MEDICINE MARKET, 2019-2027 ($ MILLION)

TABLE 15: EUROPE OTHER APPLICATION MARKET, 2019-2027 ($ MILLION)

TABLE 16: EUROPE METABOLOMICS MARKET, BY INDICATION, 2019-2027 ($ MILLION)

TABLE 17: EUROPE CANCER MARKET, 2019-2027 ($ MILLION)

TABLE 18: EUROPE CARDIOVASCULAR DISORDERS MARKET, 2019-2027 ($ MILLION)

TABLE 19: EUROPE NEUROLOGICAL DISORDERS MARKET, 2019-2027 ($ MILLION)

TABLE 20: EUROPE INBORN ERRORS OF METABOLISM MARKET, 2019-2027 ($ MILLION)

TABLE 21: EUROPE OTHER INDICATION MARKET, 2019-2027 ($ MILLION)

TABLE 22: EUROPE METABOLOMIC SMARKET, BY COUNTRY, 2019-2027 ($ MILLION)

TABLE 23: GERMANY METABOLOMICS MARKET, BY PRODUCT & SERVICE, 2019-2027 ($ MILLION)

TABLE 24: GERMANY METABOLOMICS MARKET, BY APPLICATION, 2019-2027 ($ MILLION)

TABLE 25: GERMANY METABOLOMICS MARKET, BY INDICATION, 2019-2027 ($ MILLION)

TABLE 26: FRANCE METABOLOMICS MARKET, BY PRODUCT & SERVICE, 2019-2027 ($ MILLION)

TABLE 27: FRANCE METABOLOMICS MARKET, BY APPLICATION, 2019-2027 ($ MILLION)

TABLE 28: FRANCE METABOLOMICS MARKET, BY INDICATION, 2019-2027 ($ MILLION)

TABLE 29: THE UNITED KINGDOM METABOLOMICS MARKET, BY PRODUCT & SERVICE, 2019-2027 ($ MILLION)

TABLE 30: THE UNITED KINGDOM METABOLOMICS MARKET, BY APPLICATION, 2019-2027 ($ MILLION)

TABLE 31: THE UNITED KINGDOM METABOLOMICS MARKET, BY INDICATION, 2019-2027 ($ MILLION)

TABLE 32: ITALY METABOLOMICS MARKET, BY PRODUCT & SERVICE, 2019-2027 ($ MILLION)

TABLE 33: ITALY METABOLOMICS MARKET, BY APPLICATION, 2019-2027 ($ MILLION)

TABLE 34: ITALY METABOLOMICS MARKET, BY INDICATION, 2019-2027 ($ MILLION)

TABLE 35: SPAIN METABOLOMICS MARKET, BY PRODUCT & SERVICE, 2019-2027 ($ MILLION)

TABLE 36: SPAIN METABOLOMICS MARKET, BY APPLICATION, 2019-2027 ($ MILLION)

TABLE 37: SPAIN METABOLOMICS MARKET, BY INDICATION, 2019-2027 ($ MILLION)

TABLE 38: METABOLOMICS COMPANY MARKET POSITION ANALYSIS, 2018

FIGURES LIST

FIGURE 1: EUROPE METABOLOMICS MARKET, 2019-2027 ($ MILLION)

FIGURE 2: EUROPE METAGENOMICS MARKET, BY METABOLOMICS INSTRUMENTS, 2019-2027 ($ MILLION)

FIGURE 3: EUROPE METABOLOMICS INSTRUMENTS MARKET, BY SEPARATION TECHNIQUE, 2019-2027 ($ MILLION)

FIGURE 4: EUROPE METABOLOMICS INSTRUMENTS MARKET, BY DETECTION TECHNIQUE, 2019-2027 ($ MILLION)

FIGURE 5: EUROPE METAGENOMICS MARKET, BY METABOLOMICS BIOINFORMATICS TOOLS AND SERVICES, 2019-2027 ($ MILLION)

FIGURE 6: EUROPE METABOLOMICS MARKET, BY BIOMARKER DISCOVERY, 2019-2027 ($ MILLION)

FIGURE 7: EUROPE METABOLOMICS MARKET, BY DRUG DISCOVERY, 2019-2027 ($ MILLION)

FIGURE 8: EUROPE METABOLOMICS MARKET, BY TOXICOLOGY TESTING, 2019-2027 ($ MILLION)

FIGURE 9: EUROPE METABOLOMICS MARKET, BY NUTRIGENOMICS, 2019-2027 ($ MILLION)

FIGURE 10: EUROPE METABOLOMICS MARKET, BY FUNCTIONAL GENOMICS, 2019-2027 ($ MILLION)

FIGURE 11: EUROPE METABOLOMICS MARKET, BY PERSONALIZED MEDICINE, 2019-2027 ($ MILLION)

FIGURE 12: EUROPE METABOLOMICS MARKET, BY OTHER APPLICATION, 2019-2027 ($ MILLION)

FIGURE 13: EUROPE METABOLOMICS MARKET, BY CANCER, 2019-2027 ($ MILLION)

FIGURE 14: EUROPE METABOLOMICS MARKET, BY CARDIOVASCULAR DISORDERS, 2019-2027 ($ MILLION)

FIGURE 15: EUROPE METABOLOMICS MARKET, BY NEUROLOGICAL DISORDERS, 2019-2027 ($ MILLION)

FIGURE 16: EUROPE METABOLOMICS MARKET, BY INBORN ERRORS OF METABOLISM, 2019-2027 ($ MILLION)

FIGURE 17: EUROPE METABOLOMICS MARKET, BY OTHER INDICATION, 2019-2027 ($ MILLION)

FIGURE 18: PORTER’S FIVE FORCE MODEL

FIGURE 19: GERMANY METABOLOMICS MARKET, 2019-2027 ($ MILLION)

FIGURE 20: FRANCE METABOLOMICS MARKET, 2019-2027 ($ MILLION)

FIGURE 21: THE UNITED KINGDOM METABOLOMICS MARKET, 2019-2027 ($ MILLION)

FIGURE 22: ITALY METABOLOMICS MARKET, 2019-2027 ($ MILLION)

FIGURE 23: SPAIN METABOLOMICS MARKET, 2019-2027 ($ MILLION)

FIGURE 24: REST OF EUROPE METABOLOMICS MARKET, 2019-2027 ($ MILLION)

  1. GEOGRAPHICAL ANALYSIS
    • EUROPE
      • GERMANY
      • FRANCE
      • THE UNITED KINGDOM
      • ITALY
      • SPAIN
      • REST OF EUROPE
  1. MARKET BY PRODUCT & SERVICE
    • METABOLOMICS INSTRUMENTS
      • SEPARATION TECHNIQUE
      • DETECTION TECHNIQUE
    • METABOLOMICS BIOINFORMATICS TOOLS AND SERVICES
  2. MARKET BY APPLICATION
    • BIOMARKER DISCOVERY
    • DRUG DISCOVERY
    • TOXICOLOGY TESTING
    • NUTRIGENOMICS
    • FUNCTIONAL GENOMICS
    • PERSONALIZED MEDICINE
    • OTHER APPLICATION
  3. MARKET BY INDICATION
    • CANCER
    • CARDIOVASCULAR DISORDERS
    • NEUROLOGICAL DISORDERS
    • INBORN ERRORS OF METABOLISM
    • OTHER INDICATION

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

Choose License Type

Buy Now